Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Apheresis principles in a patient with chronic myeloid leukemia during pregnancy: challenges in cell separation and assessing transcript levels

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Blood group genotyping of blood donors: validation of a highly accurate routine method

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Oral iron supplementation is not associated with short-term risk of infections: results from the Danish Blood Donor Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Frequent blood donation and offspring scholastic attainment: an assessment of long-term consequences of prenatal iron deficiency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Frequent blood donation and offspring birth weight-a next-generation association?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Genetic factors influencing hemoglobin levels in 15,567 blood donors: results from the Danish Blood Donor Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Only minor stem cell mobilization in head and neck irradiated patients treated with hyperbaric oxygen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association of the blood eosinophil count with end-organ symptoms

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Hydrochloric acid prolongs the lifetime of central venous catheters in haematologic patients with bacteraemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. International external quality assurance of JAK2 V617F quantification

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Chronic myeloid leukemia (CML) is rarely diagnosed in pregnant women.

CASE REPORT: We report a case of a pregnant woman who presented with a leukocyte count of 250 × 109 cells/L at gestational age (GA) 26 weeks and was diagnosed with CML in the chronic phase. Because the patient deliberately opted out of interferon α and tyrosine kinase inhibitor treatment, the main goal was to reduce the leukocyte count to postpone delivery beyond the number of weeks considered severely premature and avoid thromboembolic complications while continuously evaluating the clinical safety of the mother and fetus. Hence therapeutic leukapheresis was initiated, and we report the first application of an apheresis approach for this procedure using the Spectra Optia instrument without sedimentation agents. Leukapheresis was conducted 2 to 4 times per week for 9 weeks.

RESULTS: During treatment the leukocyte count decreased remarkably, and the patient developed lymphopenia together with a paradoxical increase in her blood platelet count. Premature labor was induced at GA 35 weeks, and a healthy boy was delivered. Thereafter, the patient initiated imatinib treatment and was in major molecular and complete cytogenetic remission after 1 year. Despite the remarkable reduction of the leukocyte count, we observed a pronounced increase in expression of BCR-ABL1 transcripts, implying the need for close monitoring of patients with CML during pregnancy.

CONCLUSIONS: We report a pregnant woman who was diagnosed with CML and treated solely with apheresis procedures using the Spectra Optia instrument for 9 weeks, ensuring the safe delivery of her child.

OriginalsprogEngelsk
TidsskriftTransfusion
Vol/bind59
Udgave nummer1
Sider (fra-til)39-45
Antal sider7
ISSN0041-1132
DOI
StatusUdgivet - jan. 2019

ID: 56214793